Emerging Agents in the Pipeline for Merkel Cell Carcinoma
3 Tampilan
• 07/17/23
0
0
Menanamkan
administrator
Pelanggan
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru